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With increasing knowledge of the persistence of OTA in the food chain, exposure to this mycotoxin is a potential human health haz-
ard to humans, and evaluating its presence in populations has become highly important.
A sensitive and accurate analytical method for the determination of ochratoxin A in urine was validated, since is less invasive than
blood monitoring. It involves extraction with 5% NaHCO3, immunoaffinity column (IAC) for clean-up and high performance liquid
chromatography with fluorescence detection (HPLC-FD). The limit of quantification was 0.02 ng/mL of urine (1.3 ng/mL of the extract
injected) and recovery of ochratoxin A from urine samples spiked at the three fortification levels, were higher than 90% with RSD lower
than 9%. The identification of OTA was confirmed by methyl ester derivatization and then HPLC analysis.
Based in ours first results we can assume that OTA conjugation with glucuronic acid in human urine occurs. In the present study, we
follow up OTA levels in 60 urine samples of inhabitants from Coimbra city, Portugal, in order to evaluate population contamination,
and the presence of OTA was found in 42 samples, at concentrations above the LOQ, ranged between 0.021 and 0.105 ng/mL.
 2006 Elsevier Ltd. All rights reserved.
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Ochratoxin A (OTA) is a mycotoxin produced by Peni-
cillium verrucosum, Aspergillus ochraceus and other related
species (A´lvarez et al., 2004). As to food safety, the prob-
lem of OTA lies in the fact that its presence in human body
is due to the ingestion of small quantities present in several
commodities, such as, coffee, cereals, rice, dried fruits, beer0278-6915/$ - see front matter  2006 Elsevier Ltd. All rights reserved.
doi:10.1016/j.fct.2006.04.017
Abbreviations: AOAC; BEN, Balkan endemic nephropathy; FD, flu-
orescence detection; HPLC, high performance liquid chromatography;
IAC, immunoaffinity column; IARC, International Agency for Research
on Cancer; MS, mass spectrometry; LOQ, limit of quantification; OTA,
ochratoxin A; RSD, relative standard deviation; UTT, urinary tract
tumors.
* Corresponding author. Tel.: +351 239 859994; fax: +351 239 827126.
E-mail address: apena@ci.uc.pt (A. Pena).and wine (Visconti et al., 2000; Blesa et al., 2004; Monaci
et al., 2004; Pena et al., 2005).
Toxicological profile includes nephrotoxicity, causing
both acute and chronic lesions of kidneys and has been sus-
pected to be involved in the aetiology of Balkan endemic
nephropathy (BEN), a disease characterized by progressive
renal fibrosis in humans mainly occurring in some areas of
South-Eastern Europe, and its implication in the urinary
tract tumors (UTT) (Pfohl-Leszkowicz et al., 2002; Gekle
et al., 2005). OTA is classified as a possible carcinogen to
human (Group 2B) by the International Agency for
Research on Cancer (IARC, 1993).
When ingested as a food contaminant, OTA is fre-
quently found in human blood due to the long elimination
half-life (about 35 days in serum), as consequence of its
binding to plasma proteins, its enterohepatic circulation
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This renders OTA among the most frequent mycotoxin
contaminants in human blood in the world.
Human exposure to ochratoxin A has been clearly dem-
onstrated by its detection in human blood, urine and breast
milk (Zimmerli and Dick, 1995; Thuvander et al., 2001;
Dinis et al., 2003a,b). In Portugal, higher OTA levels were
observed in the rural populations compared with the urban
populations of the zones studied (Dinis et al., 2003a), as
well as the nephropathy individuals when compared with
the healthy individuals (Dinis et al., 2003b).
Elimination in urine has been considered the main route
of OTA excretion from the human body (Li et al., 1997).
Urinary monitoring is relatively unexplored due to the
lower concentrations involved. Recent developments in
analytical methodology mean that urinary monitoring is
now more feasible and it has the advantage of being less
invasive than blood monitoring. However, data in the fre-
quency and concentration of OTA in human urine are
scarce.
The expected levels in human urine are at trace levels,
and therefore sensitive and accurate methods are required.
Liquid chromatography with fluorescence or mass spec-
trometry detection, coupled with immunoaffinity column
(IAC) clean-up, is the most widely employed analytical
methodology (Valenta, 1998; Blesa et al., 2004; Biffi
et al., 2004; Pena et al., 2005). Owing to its good native
fluorescence properties, OTA can be determined very sensi-
tively with fluorescence detection.
In the present work, the validation of a simple, sensitive
and accurate method for the urinary monitoring OTA
levels as a marker for OTA human exposure is presented.
Urine samples were extracted with 5% sodium hydrogen
carbonate followed with clean-up through immunoaffinity
column (IAC) and high performance liquid chromatogra-
phy with fluorescence detection (HPLC-FD). Positive sam-
ples were confirmed by methylation of OTA.
As glucuronide conjugates with other mycotoxins, were
found in urine, incubation with b-glucuronidase prior to
the extraction was studied in naturally contaminated sam-
ples, and based in ours first results we can assume that
OTA conjugation with glucuronic acid in human urine
occurs.
The aim of our research was to add new data to the pre-
vious studies conducted in Portuguese population blood.
Therefore, we follow up OTA levels in 60 urine samples
of healthy individuals from Coimbra city, Portugal, for a
better evaluation of Portuguese population contamination.
2. Experimental
2.1. Solvents and materials
HPLC grade acetonitrile and methanol were purchased
from Carlo Erba (Milan, Italy). Acetic acid, b-glucoroni-
dase, sodium hydrogen carbonate and sodium sulphate
anhydrous obtained from Merck (Darmstadt, Germany).Ochratoxin A and boron trifluoride 14% methanolic solu-
tion were purchased from Sigma Chemicals Co. (St. Louis,
USA).
Standard solution of ochratoxin A was prepared from
the ochratoxin A vial. The standard stock solution
(250 lg/mL) was made in 4 mL toluene–acetic acid (99:1),
and stored at 20 C. Intermediate standard solution
(10 lg/mL) was prepared diluting 1 mL of stock standard
solution with 25 mL toluene–acetic acid (99:1). The actual
concentration of the OTA was calculated using an ultravi-
olet light spectrophotometer set at 333 nm (e = 544)
(Entwisle et al., 2000).
For fortification assays, standard solution was prepared
in toluene:acetic acid (99:1) at 1000 ng/mL. For calibration
curve, the standard solutions were prepared evaporating
100 lL of intermediate standard solution at dryness, and
diluting to 10 mL with mobile phase (100 ng/mL). After
suitable dilutions in water–methanol–acetic acid
(49.5:49.5:1), the working standard solution was used to
prepare the external calibration curve (1, 5, 10, 15 and
20 ng/mL).
Imunoaffinity columns OchratestTM (Viacom/Water-
town, USA). Centrifuge Meditronic S-599 (Selecta, Barce-
lona, Spain). Vortex mixer Retsh (Haan, Germany).
Ultrasonic bath Sonorex RK 100 (Berlin, Germany).
Water was purified by distillation and passage through
Milli Q system (Millipore, Bedford, MA). All chromato-
graphic solvents and water were filtered through a
0.50 lm filter under vacuum and degassed for 15 min in
ultrasonic bath.
Amber glassware was used to prevent light. The decon-
tamination of the glassware was made by a sodium hypo-
chlorite solution. Then, it was acid washed by immersion
of the glassware in a solution of 4 mL/L H2SO4 followed
by washing to neutral pH by rinsing with distilled water.
2.2. HPLC system and chromatographic conditions
The HPLC apparatus consisted of a pump model 307
Gilson (Gilson Medical Electronics, Villiers-le-Bel,
France), an injector Rheodyne model 7125 (Cotati, Cali-
fornia, USA), and a Perkin Elmer spectrofluorimeter,
model LS45 (Perkin Elmer, Beaconsfield, UK) operated
at an excitation wavelength of 333 nm and an emission
wavelength of 477 nm. The spectral bandwidth was
10 nm for both excitation and emission. The results were
recorded on a 3390A integrator (Hewlett Packard, Phila-
delphia, USA).
Column oven for control HPLC column temperature
(30 ± 0.5 C). The results were recorded on a 3390A inte-
grator (Hewllet–Packard, Philadelphia, PA). A guard
column, C18-5 lm, Nucleosil 120 KS (30 · 4 mm i.d.),
and a column C18-5 lm, Nucleosil 100 KS (250 · 4.6 mm
i.d.) were used.
The mobile phase (acetronitrile/water/acetic acid
49.5: 49.5:1.0 v/v/v) was maintained at a flow rate of
1 mL/min.
Fig. 1. Chromatogram of a standard solution of OTA at 10 ng/mL.
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Ten milliliters volume of human urine was diluted with
10 mL of a solution of 5% NaHCO3 in distilled water,
gently mixed and filtered through Whatman No. 1 filter
paper. Then, the filtered sample was clean-up through the
OchraTestTM immunoaffinity column at a flow rate of about
1 drop/s. The column was washed twice with 5 mL distilled
water, and OTA was then slowly eluted from the column
with 3 mL of methanol HPLC grade into a glass vial and
column was dried by passing air through the column to
collect the last drops of eluate. The eluted sample was
evaporated to dryness under a gentle stream of nitrogen
at ca. 50 C and the dry residue was dissolved in 150 lL
of the HPLC mobile phase. Finally, 50 lL was injected
onto HPLC column.
The IAC columns were regenerated according to Scott
and Trucksess (1997). They were cleaned-up by passage
with 5 mL of methanol followed by 20 mL of PBS solution
and filled with PBS solution and stored until the next use.
This regeneration was never made more than once.
2.4. Sampling
A total 60 samples of human urine were collected from
healthy individuals living in Coimbra city (53 samples,
89.83%) and the countryside in central part of Portugal
(six samples, 10.17%) in November 2004. All volunteers
were asked to complete a rapid questionnaire about sex
and age.
From 60 participants involved in this study, 43%
(n = 26) were female and 57% (n = 34) were male. They
were aged between 19 and 82 years old (46.2 ± 17.8). The
women were aged between 19 and 82 years (43.8 ± 19.2)
and men were between 22 and 73 old (47.9 ± 16.1). All
samples were stored at 4 C until analysis.
2.5. Chemical confirmation of OTA by methyl ester
formation
For confirmation, the OTA was converted into its
methyl ester and two different procedures were evaluated.
In the first chemical confirmation performed according
to the method of Zimmerli and Dick (1995) 200 lL of the
extract was diluted to 2.5 mL with methanol and 0.1 mL
of 37% concentrated HCl was added. After standing over-
night at room temperature, the methanol was evaporated
and the residue dissolved in 250 lL of mobile phase.
OTA methyl ester was analyzed by liquid chromatography
accordingly to that described above. A second chemical
confirmation was carrying out following the procedure of
Castegnaro et al. (1998). Sample extracts were evaporated
to dryness, 150 lL boron trifluoride 14% methanolic solu-
tion was added, and the mixture was left at 60 C for
10 min. After evaporation, the residue was dissolved in
250 lL of mobile phase. Finally 50 lL was injected onto
HPLC column.2.6. Assay with b-glucuronidase
The assay with b-glucuronidase was performed accord-
ing to the Orti et al. (1986) method. For hydrolysis, 5 mL
of b-glucuronidase solution and 5 mL of 0.1 M Na2SO4
were added to 10 mL of urine, and the mixture was
incubated overnight (17 h) at 37 C. The hydrolyzed
urine was extracted according to the procedure above
and the extract was cleaned-up by the procedure described
above.2.7. Statistical analysis
Database management and statistical analysis were per-
formed with the SPSS 10.0 Microsoft version. To test for
significant differences between groups, the data were ana-
lyzed by ANOVA and then post-hoc analysis by Scheffe
test was performed.3. Results and discussion
3.1. HPLC conditions optimization
For the fluorescence detection a spectrum of OTA stan-
dard solution in HPLC mobile phase was obtained in order
to optimize detection of OTA. The maximum emission
wavelength at an excitation wavelength of 333 nm, was
found to be at 477 nm.
The isocratic analysis under the conditions described
allows the elution of OTA with good resolution (Fig. 1).
The mean retention time for OTA was 12.35 min. On the
basis of five parallel determinations, during five days, the
precision standard deviation within-day and between-day
(SD) of the OTA retention time, ranged from 0.02% to
0.04% and 0.03% to 0.07%, respectively.
Fig. 2. Chromatogram of a blank sample.
Table 1
Accuracy and inter- and intra-assay validation results
Fortification
level (ng/mL)
Recovery
mean (%)
RSD
within-daya (%)
RSD
between-dayb (%)
0.02 90.6 5.4 8.9
0.1 92.8 3.2 5.6
0.5 96.0 2.9 4.3
a Repeatability on the basis of three replicates at 0.02, 0.1 and 0.5 ng/mL
within the same day.
b Three days repeatability on the basis of analysis at 0.02, 0.1 and 0.5 ng/
mL/day.
1452 A. Pena et al. / Food and Chemical Toxicology 44 (2006) 1449–14543.2. Extraction and clean-up optimization
In the literature, several methods are used to determine
OTA from different type matrices, and in particular, the
extraction step is a critical point of all methods, when the
clean-up procedure employs IAC columns. The extraction
method applied was based in Pascale and Visconti method
(2001), with some modifications. After dilution with 5%
NaHCO3 and filtration the sample was cleaned up through
IAC column. Ours results showed that 2 mL of methanol
was not sufficient to elute all OTA. Therefore, to improve
clean-up efficiency, after elution of OTA with 2 mL of
methanol, a second elution with 1 mL of methanol was per-
formed, and OTA peak was found in this second eluate. In
next assay, OTA was eluted with 3 mL of methanol and
after with next 1 mL of methanol. OTA was not found in
this second eluate. So, our results indicate that 3 mL of
methanol are necessary and sufficient to elute all OTA from
IAC column. Since the eluted extracts were evaporated to
dryness and reconstituted only in 150 lL of HPLC mobile
phase, a LOQ of 0.02 ng/mL of urine (1.3 ng/mL of the
extract injected) was achieved, with good clean blank
chromatograms.
Thus, this method was applied to analyze OTA in the
urine samples. The IAC columns were regenerated accord-
ing to the Scott and Trucksess (1997) procedure. They were
cleaned-up by passage with 10 mL of methanol followed by
25 mL of PBS, and stored filled with PBS solution at 2–
8 C. This recovery was never made more than once. The
IAC columns control was made periodically and data
obtained show good reproducibility, presenting a mean
RSD of 7%.
Although unsilanized glassware was not used, it was
washed with an acidic solution in order to avoid loss of
OTA from neutral solvents by salt formation, precipitation
and/or adsorption onto glassware (Valenta, 1998; Entwisle
et al., 2000). This procedure was just effective as inactivat-
ing glassware as silanization, and easier and not so costly.
This contributes to a better accuracy and precision of the
results.
3.3. Analytical method validation
In order to verify the absence of potential interfering
substances around the retention time of OTA, a number
of representative blank urine samples (n = 10) were ana-
lyzed in order to assess the specificity of the method. No
interferences were observed in the region of interest where
the OTA was eluted as is shown in the blank sample chro-
matogram (Fig. 2).
The calibration curves were obtained using the linear
least squares regression procedure of the peak area versus
the concentration, between 1 and 10 ng/mL, 1.0; 2.5; 5.0
and 10.0 ng/mL, respectively. The linearity for OTA, in
the working standard solutions at three determinations of
five concentration levels, was good as shown by the fact
that the determination of the correlation coefficients (r2)are above 0.9990 for nine calibration curves, prepared in
three different days.
The limit of quantification (LOQ) 0.02 ng/mL of OTA
in urine, corresponding to 1.3 ng/mL of the extract
injected, was determined by the signal-to-noise approach,
defined as that level resulting in a signal-to-noise ratio of
approximately 10:1.
Within-day accuracy and the precision data were deter-
mined by analyzing, on the same day, three replicates of
spiked samples at three levels (0.02, 0.1 and 0.5 ng/mL)
and one blank (to check interferences). The between-day
accuracy and precision were also by extracting batches of
three fortification levels and analyzing them on three differ-
ent days. Accuracy and intra-day and inter-day precision
data is shown in Table 1. Under our conditions, for the
three fortification levels, recoveries from spiked urine sam-
ples for OTA reached very high values, greater than 90%
and the relative standard deviation was less than 9% dem-
onstrating good method accuracy and precision.
3.4. Confirmation by methylation of OTA
The presence of OTA in selected positive sample was
confirmed by formation of the OTA methyl ester and iden-
tified by comparing with the retention time of standard
methyl ester of OTA.
Fig. 3. Chromatogram of the OTA methyl ester.
Table 2
Mean, minimum and maximum levels (ng/mL) and frequency (%) of OTA
in urine samples
Mean Min Max % Frequency
Total 0.038 0.021 0.105 70
Male 0.039 0.022 0.105 79
20–39 0.029 0.022 0.040 91
40–60 0.062 0.036 0.105 87
61–70 0.034 0.025 0.050 25
71–80 0.032 0.028 0.050 75
Female 0.037 0.021 0.070 58
<20 0.023 0.023 0.023 100
20–39 0.038 0.030 0.050 40
40–60 0.031 0.021 0.050 60
61–70 0.060 0.060 0.060 67
71–82 0.036 0.021 0.070 100
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OTA peak and appearance of new one, corresponding to
OTA methyl ester, at retention time 31.58 min (Fig. 3).
The use of boron trifluoride (Nesheim et al., 1992) and con-
centrated hydrochloric acid (Zimmerli and Dick, 1995) as
catalysts to form the methyl ester of OTA were evaluated.
A boron trifluoride in methanol solution (14%) is used for
the preparation of the methyl ester in most methods and is
also part of the official AOAC method for OTA determina-
tion on corn and barley by HPLC (AOAC, 1997). For
boron trifluoride–methanol reagent, the recovery rate of
the methyl ester was higher (93%) when compared with
the method of Zimmerli and Dick (1995) (79%) with good
blanks.
Following the Nesheim et al. (1992) method the confir-
mation of OTA to methyl ester was performed in all
samples containing levels upper than 0.02 ng/mL urine.
3.5. Stability study
Reference literature reports that OTA solutions in meth-
anol are stable for several years at 20 C (Valenta, 1998),
but the stability of other OTA solutions prepared during
the analytical process was assessed. OTA standard solu-
tions in mobile phase were analyzed during 8 h under
laboratorial conditions (temperature  22 C). The results
obtained showed that OTA was stable under these condi-
tions for this period of time.
Although, some authors did not find changes in OTA
concentration in milk and pig kidney tissues, there are no
data on the stability of OTA in naturally contaminated
human biological material. Therefore, in this work a stabil-
ity study in naturally contaminated urine samples was
performed weekly during 1 month. Positive urine samples
were prepared according the analytical procedure described
above and inject into HPLC system. After one week we
observed a decrease of 10% in the concentration of OTA,
and after one month control the OTA concentration still
maintain in this order value (10% lower).3.6. Study with b-glucuronidase
Since a major portion of OTA is excreted in human
urine, conjugated as glucuronides, and most of the analyti-
cal methods reported for OTA analysis in urine not include
a previous hydrolysis, an assay with b-glucuronidase was
performed in four naturally contaminated samples with
0.105, 0.095, 0.081 and 0.092 ng/mL of OTA. After incuba-
tion with b-glucuronidase OTA was detected in the samples
in higher amounts: 0.290, 0.167, 0.231 and 0.195 ng/mL,
respectively. The hydrolysis procedure described here
includes the addition of sodium sulphate to the urine sample
to prevent interferences from the mucopolysaccharides that
compete for the enzyme, according to the Orti et al. (1986)
method. They included incubation with b-glucuronidase in
their method for OTA determination in human urine, how-
ever, as naturally contaminated samples were not analyzed
in this study, OTA conjugation with glucuronic acid in
human urine could not be proven.
Based in ours first results we can assume that glucuro-
nide conjugates were found in the human urine sample ana-
lyzed, but more assays should be undertaken in order to
evaluate the extension of OTA conjugation with glucuronic
acid in human urine.
3.7. Evaluation of OTA in urine samples
A total 60 samples of human urine were analyzed under
the conditions described and OTA was confirmed in 42 of
60 urine samples (70%), at concentrations above the LOQ,
ranged between 0.02 and 0.105 ng/mL (Table 2).
A study reported urine levels for endemic nephropathy
patients and for healthy individuals in Bulgaria (Maff,
1997). Urine from nephropathy patients contained OTA
in the range 0.005–0.604 ng/mL healthy individuals from
the same area had urinary levels between 0.005 and
0.043 ng/mL, while OTA was not detected in the urine of
individuals from a region that did not suffer from endemic
nephropathy.
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endemic villages OTA was found more often than in those
in non-endemic villages, and the highest levels were seen in
patients with BEN or urinary tract tumors (Petkova-
Bocharova et al., 2003).
To test for statistically significant differences between
groups, the data were analyzed by ANOVA and then
post-hoc analysis by Scheffe test was performed. Significant
differences were only observed between gender to the group
aged between 20 and 39 years (P = 0.044).
4. Conclusions
This preliminary study has shown that OTA is wide-
spread in the sample population.
We can assume that glucuronide conjugates were found
in positive human urine samples analyzed. So, in analytical
methodology applied to urine samples, a previous hydroly-
sis should be included, in order to determine free OTA and
OTA glucuronides.
The collection of urine is less invasive than blood for
follow up of population exposure, and analysis of OTA
in urine is a good marker and very useful route to monitor
OTA exposure of populations. The finding of that low
concentration of OTA in human urine samples, stresses
the problem of their toxicological significance. Given the
lack of OTA levels in human urine, the conducting of these
studies in order to evaluate food safety is highly recom-
mended. Further work is currently underway to monitor
Portuguese population as a whole.
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